At the Senate, Jesús García-Foncillas said representatives from institutions and patient groups had found common ground at the ‘Parlamentarios contra el Cáncer. Innovación, equidad y acción legislativa frente al cáncer’ event. In his closing address, the president of Fundación ECO urged political leaders to make cancer a state priority and turn agreement into defined goals sustained over time.
Spain already has a national policy framework: the Strategy in Cancer of the Spanish National Health System, coordinated by the Ministry of Health and implemented through the autonomous communities. García-Foncillas called for stronger, sustained coordination across that framework. He said policy should start with a clear picture of cancer care in Spain. Reliable data on needs in diagnosis and treatment would establish a baseline, alongside patient outcomes that help identify where the system should improve.
The Ministry of Health’s 2024 mortality data include lung and bronchial cancer rates of 69.3 deaths per 100,000 men and 26.8 per 100,000 women. The Ministry presents its health analysis through a gender-and-equity perspective, publishing mortality data alongside measures covering primary care and behavior.
Patients, he argued, should help shape policy as well as receive care. Their experience should inform decisions. García-Foncillas also called for innovation to reach patients promptly and fairly, regardless of where they live.
He linked that goal to protecting cancer research in Spain and moving its results into clinical practice. Strengthening healthcare teams is part of the same task, he said. That includes adding emerging specialists such as bioinformaticians as oncology makes greater use of data and precision medicine.
Turning those priorities into coordinated action would require a national governance model. García-Foncillas listed a national cancer agency as one option. A national institute or a commissioner could also provide that function. He said the essential test was effective coordination between initiatives.
He called for new specialised national centres to work with the existing care network in the Spanish National Health System (SNS), with organised referrals available from the early stages of illness. Specialist teams could then contribute without leaving the wider network disconnected. The Government has also approved the Statute of the State Public Health Agency, which is tasked with coordinating public-health surveillance. The cancer-governance options he outlined are distinct from Spain’s public-health agency framework described in an earlier agency report.
García-Foncillas said the model would need clear procedures and defined responsibilities, with public accountability built in. He called for continuous evaluation to establish whether measures meet their objectives and identify what needs correcting.